What is he best known for?
The fields of study he is best known for:
- Cancer
- Immune system
- Gene
Daniel A. Vallera mainly focuses on Immunology, Graft-versus-host disease, T cell, Bone marrow and Cytotoxic T cell.
His Immunology study integrates concerns from other disciplines, such as Haematopoiesis and Transplantation.
His studies deal with areas such as T lymphocyte, Interleukin 2, Cytokine, Spleen and Antibody as well as Graft-versus-host disease.
His T cell research is multidisciplinary, incorporating perspectives in Ex vivo, Cancer research, CD40, Immunotoxin and Clonogenic assay.
His work carried out in the field of Bone marrow brings together such families of science as Progenitor cell, Total body irradiation, Cyclophosphamide, Leukemia and Acute lymphocytic leukemia.
His work in Cytotoxic T cell addresses subjects such as Antigen, which are connected to disciplines such as Molecular biology.
His most cited work include:
- Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia. (293 citations)
- In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice (254 citations)
- Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice. (220 citations)
What are the main themes of his work throughout his whole career to date?
Daniel A. Vallera mainly investigates Immunology, Cancer research, Immunotoxin, Bone marrow and Molecular biology.
His study in Immunology is interdisciplinary in nature, drawing from both Cytotoxic T cell and Graft-versus-host disease, Transplantation.
His Cytotoxic T cell research incorporates elements of CD8 and Antigen.
His Cancer research research also works with subjects such as
- Antibody that intertwine with fields like Immunotherapy,
- Epidermal growth factor receptor most often made with reference to Urokinase receptor.
His Immunotoxin research integrates issues from Ricin, Diphtheria toxin, In vivo and Virology.
The concepts of his Bone marrow study are interwoven with issues in Spleen, Haematopoiesis, Stem cell and Major histocompatibility complex.
He most often published in these fields:
- Immunology (47.24%)
- Cancer research (35.83%)
- Immunotoxin (34.65%)
What were the highlights of his more recent work (between 2016-2021)?
- Cancer research (35.83%)
- Myeloid leukemia (7.09%)
- Antibody (17.32%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Cancer research, Myeloid leukemia, Antibody, Immunology and Immunotherapy.
His Cancer research research incorporates themes from Cancer, Urokinase receptor, Leukemia, CD33 and Interleukin 15.
He usually deals with CD33 and limits it to topics linked to Bone marrow and Monoclonal antibody, Total body irradiation, Multiple myeloma, Whole body imaging and Humanized antibody.
His Antibody research is multidisciplinary, relying on both Priming, Antigen and Diphtheria toxin.
His Diphtheria toxin study deals with Fusion protein intersecting with Immune system.
His Stem cell study integrates concerns from other disciplines, such as T cell and Lymphocyte.
Between 2016 and 2021, his most popular works were:
- 3D Bioprinted In Vitro Metastatic Models via Reconstruction of Tumor Microenvironments. (58 citations)
- Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy (55 citations)
- 161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS (37 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Immune system
- Gene
His primary scientific interests are in Cancer research, Immune system, Immunology, Immunotoxin and Receptor.
The concepts of his Cancer research study are interwoven with issues in Urokinase receptor, Cancer, Sarcoma and Interleukin 15.
His Immune system research integrates issues from Antibody and Stem cell.
His Immunotherapy, Interleukin 21 and Lymphokine-activated killer cell investigations are all subjects of Immunology research.
His research integrates issues of T cell, Adoptive cell transfer, Hematopoietic stem cell transplantation and Lymphocyte in his study of Immunotherapy.
Many of his studies on Immunotoxin apply to Immunogenicity as well.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
